KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Acadia Pharmaceuticals (ACAD) Tax Rate (2017 - 2025)

Acadia Pharmaceuticals (ACAD) has 9 years of Tax Rate data on record, last reported at 60.99% in Q3 2025.

  • For Q3 2025, Tax Rate fell 7689.0% year-over-year to 60.99%; the TTM value through Sep 2025 reached 5.23%, down 78.0%, while the annual FY2025 figure was 181.49%, 19374.0% down from the prior year.
  • Tax Rate reached 60.99% in Q3 2025 per ACAD's latest filing, down from 32.33% in the prior quarter.
  • Across five years, Tax Rate topped out at 82.44% in Q2 2023 and bottomed at 107.8% in Q4 2024.
  • Average Tax Rate over 5 years is 2.72%, with a median of 0.44% recorded in 2022.
  • Peak YoY movement for Tax Rate: surged 8376bps in 2023, then plummeted -9245bps in 2024.
  • A 5-year view of Tax Rate shows it stood at 0.44% in 2021, then tumbled by -362bps to 2.03% in 2022, then plummeted by -654bps to 15.35% in 2023, then crashed by -602bps to 107.8% in 2024, then surged by 43bps to 60.99% in 2025.
  • Per Business Quant database, its latest 3 readings for Tax Rate were 60.99% in Q3 2025, 32.33% in Q1 2025, and 107.8% in Q4 2024.